Senior insider sale
MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$466.2K
105.24K shares
What this filing means
PAKIANATHAN DEEPIKA plans to sell 105.24K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $466.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/22/2024ACC: 0000950170-24-099964
Director
Since Feb 2026
105.24K
Shares to sell
$466.2K
Approx. market value
105.24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of option under a registered plan
Services Rendered
8/22/2024
105.24KTotal acquired105.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/22/2024 | Exercise of option under a registered plan Services Rendered | 105.24K | — |
| Total | 105.24K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
105.24K
Market value
$466.2K
8/22/2024
Total
Units
105.24K
Value
$466.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/22/2024 | 105.24K | $466.2K | Nasdaq | Planned |
| Total | 105.24K | $466.2K | ||